N)-((S)-2-HYDROXY-3-METHYL-BUTYRYL-1-(L-ALANINYL)-(S)-1-AMINO-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-2-ONE DIHYDRATE AND ITS USE IN THE TREATMENT OF ALZHEIMER'S DISEASE

The present invention provides crystalline (N)-((S)-2-hydroxy-3-methyl-butyryl)-1-(L-alaninyl)-(S)-1-amino-3-methyl-4,5,6,7-tetrahydro-2H-3-benzazepin-2-one dihydrate, compositions thereof, and methods for using the same, processes for making the same, and processes for making intermediates thereof.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MCDANIEL, STACEY LEIGH, KOENIG, THOMAS MITCHELL, BUCCILLI, LYNNE ANN, ENGEL, GARY LOWELL, AIKINS, JAMES ABRAHAM, MITCHELL, DAVID, AUDIA, JAMES EDMUND
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention provides crystalline (N)-((S)-2-hydroxy-3-methyl-butyryl)-1-(L-alaninyl)-(S)-1-amino-3-methyl-4,5,6,7-tetrahydro-2H-3-benzazepin-2-one dihydrate, compositions thereof, and methods for using the same, processes for making the same, and processes for making intermediates thereof.